Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme

Cancer Gene Therapy

Volumn 21, Issue 7, 2014, Pages 297-303

  Schiefer, L ^a,b   Visweswaran, M ^a   Perumal, V ^a   Arfuso, F ^a   Groth, D ^a   Newsholme, P ^a   Warrier, S ^a,c   Dharmarajan, A ^a  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Manipal Academy of Higher Education   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; DNA METHYLTRANSFERASE; GENOMIC DNA; GENOMIC RNA; MEMBRANE PROTEIN; MESSENGER RNA; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 3; SECRETED FRIZZLED RELATED PROTEIN 4; SECRETED FRIZZLED RELATED PROTEIN 5; UNCLASSIFIED DRUG; FRZB PROTEIN; GLYCOPROTEIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE SILENCING; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; BRAIN TUMOR; CELL GROWTH; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS;

EID: 84904724121     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2014.30     Document Type: Article

References (43)

1. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005; 353: 811-822
2. Kreth FW, Warnke PC, Scheremet R, Ostertag CB. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 1993; 78: 762-766
3. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol 2003; 30: 10-14
4. Baba AI, Cǎtoi C. Tumor Cell Morphology. Comparative Oncology. The Publishing House of the Romanian Academy, 2007
5. Dale TC. Signal transduction by the Wnt family of ligands. Biochem J 1998; 329 (Pt 2): 209-223
6. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998; 14: 59-88
7. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-Catenin Is a Target for the ubiquitin-proteasome pathway. EMBO J 1997; 16: 3797-3804
8. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480
9. Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci USA 1997; 94: 2859-2863
10. Warrier S, Balu SK, Kumar AP, Millward M, Dharmarajan A. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells. Oncol Res 2014; 21: 93-102
11. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, Van Engeland M, Weijenberg MP et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31: 141-149
12. Suzuki H, Watkins DN, Jair K-W, Schuebel KE, Markowitz SD, Chen WD et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36: 417-422
13. Phillips T. The role of methylation in gene expression how and where are genes methylated?. Nat Educ 2008; 1: 116
14. Saran U, Arfuso F, Zeps N, Dharmarajan A. Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers. BMC Cell Biol 2012; 13: 25
15. To KKW, Zhan Z, Bates SE. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol Cell Biol 2006; 26: 8572-8585
16. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet 2000; 16: 168-174
17. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001; 10: 687-692
18. Christman JK, Mendelsohn N, Herzog D, Schneiderman N. Effect of 5-Azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60). Cancer Res 1983; 43: 763-769
19. Oue N, Shigeishi H, Kuniyasu H, Yokozaki H, Kuraoka K, Ito R et al. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 2001; 93: 805-809
20. Sharma S, Salehi F, Scheithauer BW, Rotondo F, Syro LV, Kovacs K. Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis. Anticancer Res 2009; 29: 3759-3768
21. Agrawal A, Murphy RF, Agrawal DK. DNA methylation in breast and colorectal cancers. Mod Pathol 2007; 20: 711-721
22. Kalari S, Pfeifer GP. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet 2010; 70: 277-308
23. He T. Identification of c-MYC as a Target of the APC Pathway. Science (80-) 1998; 281: 1509-1512
24. Hsieh J-C, Rattner A, Smallwood PM, Nathans J. Biochemical characterization of Wnt-Frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci USA 1999; 96: 3546-3551
25. Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC et al. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci USA 1997; 94: 6770-6775
26. Nusse R, Varmus HE. Wnt genes. Cell 1992; 69: 1073-1087
27. Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol 2000; 4: 1837-1851
28. Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J et al. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 2004; 23: 6672-6676
29. Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR et al. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 2005; 65: 7081-7085
30. Götze S, Wolter M, Reifenberger G, Müller O, Sievers S. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Int J Cancer 2010; 126: 2584-2593
31. He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N et al. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenindeficient human mesothelioma cells. Cancer Res 2005; 65: 743-748
32. Cheng YY, Yu J, Wong YP, Man EPS, To KF, Jin VX et al. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br J Cancer 2007; 97: 895-901
33. Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J et al. Frequent loss of SFRP1 expression in multiple human solid tumours: Association with aberrant promoter methylation in renal cell carcinoma. Oncogene 2007, 26: 5680-5691
34. Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R et al. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumorspecific epigenetic marker in human breast cancer. Mol Cancer 2008; 7: 83
35. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-426
36. McRonald FE, Morris MR, Gentle D, Winchester L, Baban D, Ragoussis J et al. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. Mol Cancer 2009; 8: 31
37. Ekström EJ, Sherwood V, Andersson T. Methylation and loss of Secreted Frizzled- Related Protein 3 enhances melanoma cell migration and invasion. PLoS One 2011; 6: E18674
38. Lin Y-W, Shih Y-L, Lien G-S, Suk F-M, Hsieh C-B, Yan M-D. Promoter methylation of SFRP3 is frequent in hepatocellular carcinoma. Dis Markers 2014; 2014: 351863
39. Qi J, Zhu Y-Q, Luo J, Tao W-H, Zhang J-M. Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor. Zhonghua Zhong Liu Za Zhi 2007; 29: 842-845
40. Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y et al. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett ' s esophagus. Int J Cancer 2005; 591: 584-591
41. Wang H, Wang X, Hu R, Yang W, Liao A, Zhao C et al. Methylation of SFRP5 is related to multidrug resistance in leukemia cells. Cancer Gene Ther 2014; 21: 83-89
42. Su H-Y, Lai H-C, Lin Y-W, Liu C-Y, Chen C-K, Chou Y-C et al. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer 2010; 127: 555-567
43. Valencia A, Román-Gómez J, Cervera J, Such E, Barragán E, Bolufer P et al. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia 2009; 23: 1658-1666